Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 1,157.02 |
Low | 1,157.02 |
Bid | 1,485.00 |
Offer | -- |
Previous close | 1,485.23 |
Average volume | -- |
---|---|
Shares outstanding | 157.45m |
Free float | 57.12m |
P/E (TTM) | -- |
Market cap | 12.22bn USD |
EPS (TTM) | -8.29 USD |
Data delayed at least 20 minutes, as of Nov 11 2024.
More ▼
Press releases
- Tempus Molecular Profiling Integration Now Available Through Flatiron’s OncoEMR®
- Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care
- Tempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting
- Tempus Announces the Clinical Launch of its Immune Profile Score Algorithmic Test
- Tempus Reports Third Quarter 2024 Results and Agreement to Acquire Ambry Genetics
- Tempus to Report Third Quarter 2024 Financial Results on November 4
- Tempus to Report Third Quarter 2024 Financial Results on November 7
- Tempus Announces Expansion of Collaboration with Takeda to Leverage Multimodal Real-World Datasets and Biological Model Systems in Oncology Research and Development
- Tempus Announces Four Abstracts Accepted For Presentation at the European Society for Medical Oncology Congress 2024
- Tempus Launches Beta Version of olivia, its AI-enabled Personal Health Concierge App for Patients
More ▼